Related Experiment Video
Updated: May 24, 2026

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic
Karen E Deffenbacher1, Javeed Iqbal, Warren Sanger
1Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, 68198-3135, USA.
Insights
Pediatric diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL) are distinct entities, despite similar treatment and outcomes in children. Gene expression profiling revealed unique molecular signatures and chromosomal abnormalities in pediatric DLBCL, suggesting novel therapeutic targets.
Area of Science:
- Hematology
- Pediatric Oncology
- Molecular Biology
Background:
- Burkitt lymphoma (BL) is common in children, while diffuse large B-cell lymphoma (DLBCL) is rare.
- Pediatric BL and DLBCL share similar treatment protocols and exhibit better outcomes in children than adults.
- Distinct molecular profiles differentiate pediatric DLBCL from BL, despite overlapping clinical presentations.
Purpose of the Study:
- To molecularly characterize pediatric DLBCL and compare it with adult DLBCL and pediatric BL.
- To identify genetic alterations and pathway differences that distinguish pediatric B-cell lymphomas.
- To explore potential novel therapeutic targets for pediatric B-cell non-Hodgkin lymphoma.
Main Methods:
- Gene expression profiling (GEP) and miRNA expression profiling were used to cluster pediatric and adult lymphoma samples.
- Pathway analysis of GEP data was performed to identify molecular differences.
- Array-based comparative genomic hybridization (CGH) was employed to detect chromosomal abnormalities.
Main Results:
- GEP and miRNA profiling clearly separated pediatric DLBCL from BL into distinct clusters.
- Pediatric DLBCL showed a predominance of the germinal center B-cell subtype (6:1 ratio).
- Frequent 8q24 abnormalities, including MYC alterations, were observed in pediatric DLBCL (31% rearrangement, 50% gain/amplification).
- MYC rearrangement was highly prevalent in BL (96%).
- CGH analysis revealed shared and unique chromosomal abnormalities between pediatric and adult DLBCL, suggesting distinct pathogenetic mechanisms.
Conclusions:
- Pediatric DLBCL and BL are molecularly distinct entities.
- Pediatric DLBCL harbors unique genetic alterations, including MYC pathway involvement and specific chromosomal abnormalities.
- These findings highlight age-related pathogenetic differences and suggest potential novel therapeutic targets for pediatric B-cell lymphomas.
Abstract:
Burkitt lymphoma (BL) predominates in pediatric patients, whereas diffuse large B-cell lymphoma (DLBCL) is uncommon. In contrast to adults, BL and DLBCL are treated similarly in children and both entities have superior outcomes in children compared with adults. Gene expression profiling (GEP) and miRNA expression profiling clearly differentiated pediatric DLBCL from BL, forming distinct clusters regardless of patient age. However, pathway analysis of GEP data identified minor differences between corresponding pediatric and adult tumors. Predominance (6:1) of the germinal center B-cell subtype to activated B-cell subtype was found among pediatric DLBCL. Two cases were molecularly classified as primary mediastinal B-cell lymphoma. We observed frequent abnormalities in 8q24 in pediatric DLBCL, including MYC rearrangement in 31% (5 of 16) and gain or amplification in 50% (6 of 12) nonrearranged cases. MYC rearrangement was present in 96% (23 of 24) BL cases. Array-based CGH analysis identified abnormalities that are shared between adult and pediatric DLBCL (+12q15, +19q13, -6q), and abnormalities unique to the pediatric cases (-4p14, -19q13.32, +16p11.2), suggesting distinct pathogenetic mechanisms relative to age. Elucidation of the underlying target genes may provide insight into factors that modulate outcome and could provide potential novel therapeutic targets with less toxicity for pediatric patients with B-cell non-Hodgkin lymphoma.
More Related Videos
Related Concept Videos
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Modern Molecular Taxonomy
Differentiation of Common Myeloid Progenitor Cells

